Centiva Capital »

Lucid Diagnostics shares owned by Centiva Capital

Quarter-by-quarter ownership of Lucid Diagnostics (LUCD) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Lucid Diagnostics

Tip: Access up to 7 years of quarterly data

All positions including Lucid Diagnostics held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lucid Diagnostics by Centiva Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $25k 25k 1.01

More positions owned by Centiva Capital

Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Tesla Motors (TSLA)
Regeneron Pharmaceuticals Call Option (REGN)
Pdd Holdings Sponsored Ads (PDD)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Amazon (AMZN)
Kraneshares Trust Csi Chi Internet Put Option (KWEB)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)

View all positions for Centiva Capital

Top funds holding Lucid Diagnostics

Vanguard Group
Masters Capital Mgmt
BlackRock
Standard Life Aberdeen
Two Seas Capital
AWM Investment Company
Ghisallo Capital Management
Geode Capital Management
Alyeska Investment Group
Perkins Capital Management
State Street Corporation
Luminus Management
Wells Fargo & Company
Goldman Sachs Group
Northern Trust

View all funds holding Lucid Diagnostics